- Novo Nordisk enters bidding war with Pfizer over US biotech Metsera Reuters
- European markets negative; Novo Nordisk drops 3% after surprise bid for Metsera CNBC
- Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera The Wall Street Journal
- Novo Offers $6.5 Billion for Metsera to Challenge Pfizer Bloomberg.com
- Pfizer Addresses Proposal for Metsera Business Wire
